Report : Asia Pacific Medical Photobiostimulation System Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Infrared Light, Red Light, and Others) and Application (Pain Management, Wound Care, Cosmetic Applications, and Others)
Infrared Light Segment has the Largest Share of Product in the Asia Pacific Medical Photobiostimulation System Market during 2021–2028
According to our latest study on “Asia Pacific Medical Photobiostimulation System Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product and Application,” the market is projected to reach US$ 60.6 million by 2028 from US$ 37.5 million in 2021; it is expected to grow at a CAGR of 7.1% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the growing number of patients suffering from chronic disorders and chronic pain and rising demand for photobiostimulation devices for pain management and wound care due to increasing geriatric population boost the market growth. However, stringent regulatory framework hampers the market growth.
Based on product, the medical photobiostimulation system market is segmented into infrared light, red light, and others. In 2021, the infrared light segment is estimated to account for the largest market share in the Asia Pacific medical photobiostimulation system market. The growth of the segment is attributed to increasing adoption in pain management such as arthritis, osteoporosis, and rising geriatric population.
BioLight Technologies LLC., Ingeneus, Omega Laser Systems Ltd, Vielight Inc., Theradome Inc., Lexington Intl., LLC, THOR Photomedicine Ltd, Meditech International Inc. (BIOFLEX Laser Therapy), and Apira Science, Inc. (iGrow Laser) are among the leading companies in the Asia Pacific medical photobiostimulation system market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for medical photobiostimulation system market is segmented into product and application. Based on product, the Asia Pacific medical photobiostimulation system market is segmented into infrared light, red light, and others. Based on application, the medical photobiostimulation system market is segmented into pain management, wound care, cosmetic applications, and others. Geographically, the medical photobiostimulation system market is segmented into Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com